BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 16573651)

  • 1. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
    Casarejos MJ; Menéndez J; Solano RM; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
    J Neurochem; 2006 May; 97(4):934-46. PubMed ID: 16573651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences and estrogen effects in parkin null mice.
    Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Gomez A; Perucho J; de Yébenes JG; Mena MA
    J Neurochem; 2008 Sep; 106(5):2143-57. PubMed ID: 18643794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.
    Casarejos MJ; Solano RM; Menéndez J; Rodríguez-Navarro JA; Correa C; García de Yébenes J; Mena MA
    J Neurochem; 2005 Aug; 94(4):1005-14. PubMed ID: 16000163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis.
    Casarejos MJ; Solano RM; Rodriguez-Navarro JA; Gómez A; Perucho J; Castaño JG; García de Yébenes J; Mena MA
    J Neurochem; 2009 Sep; 110(5):1523-37. PubMed ID: 19549073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial dysfunction in parkin null mice: effects of aging.
    Solano RM; Casarejos MJ; Menéndez-Cuervo J; Rodriguez-Navarro JA; García de Yébenes J; Mena MA
    J Neurosci; 2008 Jan; 28(3):598-611. PubMed ID: 18199761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline protects dopaminergic neurons against long-term rotenone toxicity.
    Radad K; Moldzio R; Rausch WD
    Can J Neurol Sci; 2010 Jan; 37(1):81-5. PubMed ID: 20169778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
    Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
    Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.
    Wu DC; Jackson-Lewis V; Vila M; Tieu K; Teismann P; Vadseth C; Choi DK; Ischiropoulos H; Przedborski S
    J Neurosci; 2002 Mar; 22(5):1763-71. PubMed ID: 11880505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalpol attenuates nitric oxide increase via ERK signaling pathways induced by rotenone in mesencephalic neurons.
    Bi J; Jiang B; Hao S; Zhang A; Dong Y; Jiang T; An L
    Neurochem Int; 2009; 54(3-4):264-70. PubMed ID: 19111870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis.
    Hirata Y; Meguro T; Kiuchi K
    J Neurochem; 2006 Oct; 99(2):416-25. PubMed ID: 17029596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.
    Gao HM; Liu B; Hong JS
    J Neurosci; 2003 Jul; 23(15):6181-7. PubMed ID: 12867501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38(MAPK)/p53-Mediated Bax induction contributes to neurons degeneration in rotenone-induced cellular and rat models of Parkinson's disease.
    Wu F; Wang Z; Gu JH; Ge JB; Liang ZQ; Qin ZH
    Neurochem Int; 2013 Sep; 63(3):133-40. PubMed ID: 23714208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin null cortical neuronal/glial cultures are resistant to amyloid-β1-42 toxicity: a role for autophagy?
    Solano RM; Casarejos MJ; Gómez A; Perucho J; de Yébenes JG; Mena MA
    J Alzheimers Dis; 2012; 32(1):57-76. PubMed ID: 22785397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
    Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
    Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death.
    Grammatopoulos TN; Ahmadi F; Jones SM; Fariss MW; Weyhenmeyer JA; Zawada WM
    Brain Res; 2005 May; 1045(1-2):64-71. PubMed ID: 15910763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
    Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
    J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice.
    Serrano A; Menéndez J; Casarejos MJ; Solano RM; Gallego E; Sánchez M; Mena MA; García de Yebenes J
    Neuropharmacology; 2005 Aug; 49(2):208-19. PubMed ID: 15993444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.
    Kim SR; Chung ES; Bok E; Baik HH; Chung YC; Won SY; Joe E; Kim TH; Kim SS; Jin MY; Choi SH; Jin BK
    J Neurosci Res; 2010 May; 88(7):1537-48. PubMed ID: 20025058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K; Miller DB; O'Callaghan JP
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.